Clinical trial
This Study is a Multi-center, Prospective, Single-armed, Study Designed to Evaluate the Safety and Feasibility of the BioVentrix PliCath HF System for Left Ventricular (LV) Volume and Radius Reduction Through Scar Exclusion in Patients Whose Systolic HF is Due to Ischemic Cardiomyopathy.
NCT01568138 is registered in ClinicalTrials.gov with BioVentrix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- This Study is a Multi-center, Prospective, Single-armed, Study Designed to Evaluate the Safety and Feasibility of the BioVentrix PliCath HF System for Left Ventricular (LV) Volume and Radius Reduction Through Scar Exclusion in Patients Whose Systolic HF is Due to Ischemic Cardiomyopathy.
- Lead sponsor
- BioVentrix
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- August 31, 2015
- Enrollment
- 26 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.